X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
asas consensus statement (57) 57
index medicus (57) 57
rheumatology (55) 55
ankylosing spondylitis (50) 50
female (35) 35
male (34) 34
spondylitis, ankylosing - drug therapy (33) 33
adult (31) 31
antirheumatic agents - therapeutic use (31) 31
tumor necrosis factor-alpha - antagonists & inhibitors (30) 30
infliximab (27) 27
severity of illness index (25) 25
treatment outcome (25) 25
double-blind (24) 24
middle aged (23) 23
placebo-controlled trial (22) 22
efficacy (19) 19
etanercept (18) 18
agents (17) 17
ankylosing-spondylitis (15) 15
antibodies, monoclonal - therapeutic use (15) 15
spondylitis, ankylosing - diagnosis (15) 15
care and treatment (13) 13
rheumatoid-arthritis (13) 13
spondyloarthritis (13) 13
medicine & public health (12) 12
patients (12) 12
abridged index medicus (11) 11
drug therapy (11) 11
spondylitis, ankylosing - physiopathology (11) 11
tumor necrosis factor (11) 11
arthritis (10) 10
practice guidelines as topic (10) 10
prospective studies (10) 10
spondylitis, ankylosing - therapy (10) 10
adalimumab (9) 9
analysis (9) 9
axial spondyloarthritis (9) 9
diagnosis (9) 9
disease-activity (9) 9
multicenter (9) 9
psoriatic-arthritis (9) 9
quality-of-life (9) 9
radiographic progression (9) 9
spondylitis (9) 9
tumor-necrosis-factor (9) 9
anti-inflammatory agents, non-steroidal - therapeutic use (8) 8
inflammation (8) 8
internal medicine (8) 8
short-term improvement (8) 8
studies (8) 8
therapy (8) 8
tumor necrosis factor-tnf (8) 8
aged (7) 7
anti-tnf agents (7) 7
antibodies, monoclonal, humanized (7) 7
asa (7) 7
asas (7) 7
health status (7) 7
immunoglobulin g - therapeutic use (7) 7
necrosis-factor-alpha (7) 7
quality of life (7) 7
receptors, tumor necrosis factor - therapeutic use (7) 7
safety (7) 7
spondylitis, ankylosing - immunology (7) 7
spondyloarthropathy (7) 7
tumors (7) 7
antirheumatic agents (6) 6
antirheumatic agents - adverse effects (6) 6
dosage and administration (6) 6
health aspects (6) 6
immunology (6) 6
index (6) 6
inflammatory diseases (6) 6
medicine, general & internal (6) 6
nonsteroidal antiinflammatory drugs (6) 6
psoriatic arthritis (6) 6
recommendations (6) 6
research (6) 6
rheumatoid arthritis (6) 6
update (6) 6
anti-tnf (5) 5
anti-tnf therapy (5) 5
basdai (5) 5
bath (5) 5
c-reactive protein (5) 5
disability evaluation (5) 5
disease (5) 5
disease progression (5) 5
drugs (5) 5
magnetic resonance imaging (5) 5
medical research (5) 5
medicine, experimental (5) 5
nonsteroidal anti-inflammatory drugs (5) 5
pain (5) 5
rheumatic diseases (5) 5
society classification criteria (5) 5
spondylarthritis - diagnosis (5) 5
surgery (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2007, Volume 369, Issue 9570, pp. 1379 - 1390
Summary Ankylosing spondylitis is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which... 
Internal Medicine | RANDOMIZED CONTROLLED TRIAL | ASAS CONSENSUS STATEMENT | MEDICINE, GENERAL & INTERNAL | TUMOR-NECROSIS-FACTOR | SHORT-TERM TREATMENT | HLA-B27 POSITIVE INDIVIDUALS | DOUBLE-BLIND | OPEN-LABEL TRIAL | PLACEBO-CONTROLLED TRIAL | RESONANCE-IMAGING EXAMINATIONS | INFLAMMATORY BACK-PAIN | Prevalence | Humans | Spondylitis, Ankylosing - drug therapy | HLA-B Antigens - immunology | Male | Spondylitis, Ankylosing - physiopathology | Radiography | Spondylitis, Ankylosing - immunology | Sacroiliac Joint - pathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Treatment Failure | Adult | Female | HLA-B Antigens - adverse effects | HLA-B Antigens - genetics | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Antirheumatic Agents - therapeutic use | Sacroiliac Joint - diagnostic imaging | Drug therapy | Ankylosing spondylitis | Diagnosis | Inflammatory bowel disease | Costs | Back pain | Sensitivity analysis | Chlamydia | Bowel disease | Rheumatic diseases | Bone density | Patients | Pathogenesis | Arthritis | Family medical history | Bone (axial) | Epidemiology | Market shares | Pain | Conflicts of interest | Nonsteroidal anti-inflammatory drugs | Antiinflammatory agents | Psoriasis | Cytokines | Physiotherapy | Imaging techniques | Inflammation | Disease control | Quality of life | Spondylitis | Tumor necrosis factor | Structural damage | Tumors | Structure-function relationships
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2006, Volume 65, Issue 4, pp. 442 - 452
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2011, Volume 70, Issue 1, pp. 157 - 163
Journal Article
Journal of Rheumatology, ISSN 0315-162X, 09/2016, Volume 43, Issue 9, pp. 1680 - 1686
Objective. To establish cutoffs for the minimum clinically important improvement (MCII) and the patient-acceptable symptom state (PASS) for the Bath Ankylosing... 
Basfi | Pa